Product
Tafluprost + Timolol
1 clinical trial
2 indications
Indication
Open-angle GlaucomaIndication
ocular hypertensionClinical trial
A Randomized, Double-masked, Controlled Parallel Group, Multi-center Study of DE-111A (Fixed Dose Combination of Tafluprost and Timolol Eye Drops) on the Treatment of Open Angle Glaucoma or Ocular Hypertension (With Tafluprost Eye Drops as a Comparator)Status: Completed, Estimated PCD: 2023-04-04